Year archive

POOLBEG PHARMA PLC — 2024 filings

All 22 regulatory filings released by POOLBEG PHARMA PLC (POLB) in 2024, sourced directly from the official regulator.

22 Filings

2024 Period

2024 filings (22)

Filing	Released	Lang
Poolbeg presents POLB 001 data at 66th ASH Meeting Regulatory Filings	2024-12-09	English
POLB 001 Patent Granted in United States Regulatory Filings	2024-11-20	English
POLB 001 data to be presented at ASH Regulatory Filings	2024-11-06	English
Interim results for the six months to 30 June 2024 Earnings Release H1 2024	2024-09-18	English
H.C. Wainwright Global Investment Conference Investor Presentation	2024-08-27	English
Holding(s) in Company Major Shareholding Notification	2024-08-12	English
Voluntary Delisting from OTCQB Market Delisting Announcement	2024-07-26	English
Notification of Major Holdings Major Shareholding Notification	2024-07-10	English
Change of Registered Address Regulatory Filings	2024-07-02	English
Result of AGM AGM Information	2024-06-17	English
Annual Report & AGM Notice Report Publication Announcement	2024-05-09	English
Significant POLB 001 Patent Granted in USA Regulatory Filings	2024-05-01	English
Appointment of Joint Broker Regulatory Filings	2024-04-30	English
Option Agreement to Acquire Orphan Drug Candidate M&A Activity	2024-04-30	English
Results for the year ended 31 December 2023 Report Publication Announcement FY 2023	2024-04-30	English
TR-1: Notification of major holdings Major Shareholding Notification	2024-04-29	English
POLB 001 US Patent Update Legal Proceedings Report	2024-03-20	English
Director/PDMR Shareholding Director's Dealing	2024-02-22	English
Director Share Purchase Director's Dealing	2024-02-19	English
Board Role Change and Launch of EIP Director's Dealing	2024-02-15	English
Market Opportunity for POLB 001 for CRS Regulatory Filings	2024-02-12	English
Further data shows POLB001 potential in cancer CRS Regulatory Filings	2024-01-17	English